A drug that boosts activity in the brain’s “garbage disposal” system can decrease levels of toxic proteins associated with Alzheimer’s disease and other neurodegenerative disorders and improve cognition in mice.
A new study of Alzheimer's in people with Down Syndrome may lead to tests that detect Alzheimer's early.
Three successful movies from this year's Oscars featured strong medicine and science narratives.
During National Alzheimer’s Disease Awareness Month, we look at Scott Small’s newest Alzheimer’s research.
Columbia is part of a new consortium to identify rare genetic variants that may protect against, or contribute to Alzheimer’s disease.
Recent research at Columbia has shed light on an important risk marker for Alzheimer’s—"white matter hyperintensities" (WMH).